Microglial Progranulin: Involvement in Alzheimer’s Disease and Neurodegenerative Diseases
Neurodegenerative diseases such as Alzheimer’s disease have proven resistant to new treatments. The complexity of neurodegenerative disease mechanisms can be highlighted by accumulating evidence for a role for a growth factor, progranulin (PGRN). PGRN is a glycoprotein encoded by the GRN/G...
Main Authors: | Anarmaa Mendsaikhan, Ikuo Tooyama, Douglas G. Walker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | http://www.mdpi.com/2073-4409/8/3/230 |
Similar Items
-
Characterization of lysosomal proteins Progranulin and Prosaposin and their interactions in Alzheimer’s disease and aged brains: increased levels correlate with neuropathology
by: Anarmaa Mendsaikhan, et al.
Published: (2019-12-01) -
Alzheimer’s Disease Research Using Human Microglia
by: Lih-Fen Lue, et al.
Published: (2019-08-01) -
Differences in Gene Expression Profiles and Phenotypes of Differentiated SH-SY5Y Neurons Stably Overexpressing Mitochondrial Ferritin
by: Anarmaa Mendsaikhan, et al.
Published: (2019-01-01) -
Mitochondrial regulation of microglial immunometabolism in Alzheimer’s disease
by: Fairley, Lauren H., et al.
Published: (2021) -
Microglial Immunometabolism in Alzheimer’s Disease
by: Daniel C. Shippy, et al.
Published: (2020-09-01)